{
    "Additional Indicators": [
        {
            "description": "Unfavorable Prognosis",
            "therapy": "NCCN, Consensus, Non-Small Cell Lung Cancer",
            "mutation": "KRASp.G12C Gain-of-function"
        }
    ],
    "Clinical trials": [
        {
            "description": "A Study of VS-6766 v. VS-6766 + Defactinib in Recurrent G12V, Other KRAS and BRAF Non-Small Cell Lung Cancer ",
            "phase": "Phase 2",
            "mutations": [
                "KRAS"
            ]
        },
        {
            "description": "A Phase 1/2 Study of MRTX849 in Patients With Cancer Having a KRAS G12C Mutation KRYSTAL-1",
            "phase": "Phase 1/2",
            "mutations": [
                "KRAS",
                "STK11"
            ]
        },
        {
            "description": "First-in-human Study of DRP-104 (Sirpiglenastat) as Single Agent and in Combination With Atezolizumab in Patients With Advanced Solid Tumors. (NCT04471415)",
            "phase": "Phase 1/2",
            "mutations": [
                "NFE2L2",
                "STK11"
            ]
        }
    ],
    "variants of unknown significance": {
        "Somatic": [
            {
                "Gene": "FGFR1",
                "DNA Alteration": "c.1966A>G",
                "GeneMutation": "p.K656E Frameshift-LOF",
                "VariantAlleleFraction": "6.58%"
            },
            {
                "Gene": "ARID2",
                "DNA Alteration": " c.798G>A",
                "GeneMutation": " p.W266* Spliceregionvariant-LOF",
                "VariantAlleleFraction": "18.0%"
            },
            {
                "Gene": "RNF43",
                "DNA Alteration": "c.505G>A",
                "GeneMutation": "p.A169T Nonsense-GOF",
                "VariantAlleleFraction": "8.93%"
            },
            {
                "Gene": "PIK3CA",
                "DNA Alteration": "c.1624G>C",
                "GeneMutation": "p.E545G Frameshift-GOF",
                "VariantAlleleFraction": "1.99%"
            },
            {
                "Gene": "TP53",
                "DNA Alteration": "c.743G>A",
                "GeneMutation": "p.V272M Frameshift-GOF",
                "VariantAlleleFraction": "4.02%"
            },
            {
                "Gene": "B2M",
                "DNA Alteration": "c.2T>G",
                "GeneMutation": "p.M1R Spliceregionvariant-LOF",
                "VariantAlleleFraction": "6.01%"
            },
            {
                "Gene": "EGFR",
                "DNA Alteration": "c.866C>A",
                "GeneMutation": "p.V769M Spliceregionvariant-GOF",
                "VariantAlleleFraction": "9.45%"
            },
            {
                "Gene": "STAG2",
                "DNA Alteration": "c.3113A>G",
                "GeneMutation": "p.R1012X Spliceregionvariant-LOF",
                "VariantAlleleFraction": "6.99%"
            },
            {
                "Gene": "PHF6",
                "DNA Alteration": "c.3113A>G",
                "GeneMutation": "p.R225X Spliceregionvariant-LOF",
                "VariantAlleleFraction": "7.08%"
            },
            {
                "Gene": "CDKN2A",
                "DNA Alteration": "c.248_249delinsCT",
                "GeneMutation": "p.A102V Missensevariant(exon2)-GOF",
                "VariantAlleleFraction": "1.19%"
            }
        ],
        "Germline": []
    }
}